Targeting a neoantigen derived from a common <i>TP53</i> mutation

Emily Han-Chung Hsiue, Katharine M. Wright, Jacqueline Douglass, +22

Science

Bispecific antibodies targeting mutant<i>RAS</i>neoantigens

Jacqueline Douglass, Emily Han-Chung Hsiue, Brian J. Mog, +23

Science Immunology

Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer

Md. Zahidunnabi Dewan, Claire Vanpouille‐Box, Noriko Kawashima, +5

Clinical Cancer Research

IL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques

Ana M. Ortiz, Zachary Klase, Sarah R. DiNapoli, +12

Mucosal Immunology

Th17 FrequenciesDysbiosisImmunologySiv-infected MacaquesMicrobiology +4

Targeting loss of heterozygosity for cancer-specific immunotherapy

Michael S. Hwang, Brian J. Mog, Jacqueline Douglass, +12

Proceedings of the National Academy of Sciences

Tissue-resident macrophages can contain replication-competent virus in antiretroviral-naive, SIV-infected Asian macaques

Sarah R. DiNapoli, Alexandra M. Ortiz, Fan Wu, +5

JCI Insight

TCR β chain–directed bispecific antibodies for the treatment of T cell cancers

Suman Paul, Alexander H. Pearlman, Jacqueline Douglass, +17

Science Translational Medicine

ImmunologyImmunotherapeuticsCd4 T Cell ResponsesImmune Cell TherapyT Cells +16

Microbial Translocation and Inflammation Occur in Hyperacute Immunodeficiency Virus Infection and Compromise Host Control of Virus Replication

Adam J. Ericsen, Michael Lauck, Mariel S. Mohns, +18

PLoS Pathogens

Experimental microbial dysbiosis does not promote disease progression in SIV-infected macaques

Alexandra M. Ortiz, Jacob K. Flynn, Sarah R. DiNapoli, +12

Nature Medicine

DysbiosisMicrobial DiseaseDisease ProgressionPathogen TransmissionExperimental Microbial Dysbiosis +10

TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers

Tushar D. Nichakawade, Jiaxin Ge, Brian J. Mog, +23

Nature

Tumor ImmunologyCancer ImmunosurveillanceDrug TargetingMedicineImmunology +8